Ignite Creation Date:
2025-12-24 @ 7:59 PM
Ignite Modification Date:
2026-02-20 @ 4:43 PM
Study NCT ID:
NCT02780804
Status:
COMPLETED
Last Update Posted:
2023-10-17
First Post:
2016-05-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Brain Stem Neoplasm | View |
| None | Pineal Region Neoplasm | View |
| None | Recurrent Lymphoma | View |
| None | Recurrent Malignant Solid Neoplasm | View |
| None | Recurrent Primary Central Nervous System Neoplasm | View |
| None | Recurrent Visual Pathway Glioma | View |
| None | Refractory Lymphoma | View |
| None | Refractory Malignant Solid Neoplasm | View |
| None | Refractory Primary Central Nervous System Neoplasm | View |
| None | Refractory Visual Pathway Glioma | View |
Keywords: